Member Info for zebbo

Pharma just need to label everything with "drugs can kill", same as a packet of fags. Job done

Danger is if they keep getting sued, they will just shut up shop...........Then what happens

$$ strength makes GSK look extremely cheap at the moment. I would not be surprised if a low ball offer comes in

Again, lots of could, may. All unproven scientifically.

These law firms that just look for angles. They may have the angles of "may" & "could", way to subjective IMHO.

Data tells you its a non runner. These firms are chancers playing law of averages. IMO we will grind back up to normal trading levels

Guys, its a money making game. Recent example is "if you owned a diesel car between 20xx & 20xx you may have been mis sold" due to emissions. Sign up with your details. The legal people will then try and take the manufacturers to court and if they win you get ~60% they get ~40% These "legal" firms need the likes of you and me to sign up in order to provide weight to the case. Of course Joe public signs up as he/she may get a few £000 for zero effort
Just a money making game for legal, clutching at straws. Probably splitting fees with the the defense also...lol. Low level blood suckers IMO

Since 2019, the medical, scientific, and regulatory communities have extensively
evaluated the safety of Zantac’s active ingredient ranitidine, and the data shows there
is no evidence of consumer harm from real-world use of Zantac. Over time, both FDA
and the European Medicines Agency have evaluated the available data and found no
evidence that ranitidine causes cancer.

https://ml-eu.globenewswire.com/Resource/Download/174c9e60-f7c3-4b63-b8c2-2f2033ca4c53

Sanofi media, opening statement below. News release worth a read for some perspective.
Paris, August 11, 2022.
In response to the recent highly speculative news flow regarding the U.S. Zantac
litigation at a time when there have not been any material developments,
Sanofi remains confident in its legal defenses and wishes to make the following
statement, consistent with what has been disclosed previously:...........................

I think they will want to be sure of their standing before issuing a statement

Their role is to get the best outcome possible. Could be bugger all, could be $50m

We just need to see what happens

Does anyone know what the SP would be today at pre de merger rates

Either way, this is going to be hard to prove. Sanofi have already stated that.

Also that Sanofi had the US distribution/ownership rights etc

Sanofi has previously downplayed the risks of the litigation, with executives saying on an earnings call last month that there’s no reliable evidence that Zantac causes cancer and that plaintiffs won’t be able to prove their claims

they just make it up as they go along - Company need to RNS our liability NOW..

Porsche, as usual, you aint got a clue what you are talking about.
Posting same old rubbish time and time again. Keyboard warrior at best

Apologies, I was a week ahead...Doh.. You are correct the 18th

II selling ahead of ex divi date ie tomorrow

Should be a lot higher. Ive got a good chunk and expect a rising well towards £2 by next year.

Some saying 110p re list, that feels a bi rich to me, but who knows. Exciting times ahead for sure with this management team

Talk about drag it out, we must be there sooooooooooooon

Due to the commercial sensitivity of this sales process, we can only provide limited narrative as to the exact progress to date. Offer deadlines have been set with all interested parties and the details of indicative offers received cannot be disclosed subject to confidentiality agreement provisions. - "So we have had offers and deadlines set"

Alongside the above sale of business activity, we continue to explore the possibility of a refinance of the Group and an exit from administration. Similarly to above, progress here is confidential and updates will be made available to creditors at the appropriate time. - "so we are actively looking at re financing"

Worst case looks to be around 3p per share ie £7.4M, take off c£1.4 for wages/fees = £6M to distribute. Thats my take

= same poster, note language used is similar.
further look is even funnier, they "both" post on the same shares...doh